Search
Novavax Inc
NVAXAdd to Watchlist
10.110USD
+0.110+1.10%
Close 09-18 16:00（ET）
1.66BMarket Cap
LossP/E TTM
After-hours 17:24 (ET)10.020USD-0.090-0.89%
After-hours 17:24 (ET)Novavax Inc (NVAX) Revenue Performance
Updated: Jun 30, 2026Last year, Novavax Inc generated 685.04M USD for its biggest-performing segment, Product. The Canada made the largest contribution, accounting for 575.67M USD last year. For the latest quarter, Novavax Inc reported the revenue of 37.84M USD for the period ending 2026-06-30, which came from the top-performing segment, Licensing Royalties And Other. United States contributed the highest revenue, at 38.44M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Product
Licensing Royalties And Other
Grant
FY2025
Product
685.04M(60.97%)
Licensing Royalties And Other
438.44M(39.03%)
Grant
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
Canada
United States
Rest of the world
Europe
FY2025
Canada
575.67M(51.24%)
United States
405.61M(36.10%)
Rest of the world
126.46M(11.26%)
Europe
15.74M(1.40%)